Simon Broome confirms that the IAS definition of severe familial hypercholesterolemia predicts coronary mortality in patients with FH (Englisch)
- Neue Suche nach: Santos, Raul D.
- Neue Suche nach: Watts, Gerald F.
- Neue Suche nach: Santos, Raul D.
- Neue Suche nach: Watts, Gerald F.
In:
Atherosclerosis
;
281
;
145-147
;
2019
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:Simon Broome confirms that the IAS definition of severe familial hypercholesterolemia predicts coronary mortality in patients with FH
-
Beteiligte:Santos, Raul D. ( Autor:in ) / Watts, Gerald F. ( Autor:in )
-
Erschienen in:Atherosclerosis ; 281 ; 145-147
-
Verlag:
- Neue Suche nach: Elsevier Science B.V., Amsterdam.
-
Erscheinungsdatum:01.01.2019
-
Format / Umfang:3 pages
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 616.136
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 616.136 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 281
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
Systematic prediction of familial hypercholesterolemia caused by low-density lipoprotein receptor missense mutationsGuo, Jiayan / Gao, Yan / Li, Xun / He, Ying / Zheng, Xin / Bi, Jianjun / Hou, Libo / Sa, Yinxi / Zhang, Mingqiang / Yin, Hong et al. | 2019
- 9
-
Adverse interaction between HDL and the mass of myocardial infarctionSoares, Alexandre A.S. / Carvalho, Luiz Sergio F. / Bonilha, Isabella / Virginio, Vitor W. / Nadruz Junior, Wilson / Coelho-Filho, Otavio Rizzi / Quinaglia e Silva, Jose C. / Petrucci Junior, Orlando / Sposito, Andrei C. et al. | 2019
- 17
-
Plasma levels of apolipoproteins C-III, A-IV, and E are independently associated with stable atherosclerotic cardiovascular diseaseDittrich, Julia / Beutner, Frank / Teren, Andrej / Thiery, Joachim / Burkhardt, Ralph / Scholz, Markus / Ceglarek, Uta et al. | 2019
- 25
-
Lipoprotein(a) as a risk factor for calcific aortic valvulopathy in heterozygous familial hypercholesterolemiaVuorio, Alpo / Watts, Gerald F. / Kovanen, Petri T. et al. | 2019
- 31
-
Adipose tissue macrophages do not affect atherosclerosis development in miceBijnen, Mitchell / van de Gaar, José / Vroomen, Maria / Gijbels, Marion J. / de Winther, Menno / Schalkwijk, Casper G. / Wouters, Kristiaan et al. | 2019
- 38
-
LncRNA HOXA-AS2 represses endothelium inflammation by regulating the activity of NF-κB signalingZhu, Xinxing / Liu, Yanli / Yu, Jinjin / Du, Jiang / Guo, Rui / Feng, Yanyan / Zhong, Genshen / Jiang, Yizhou / Lin, Juntang et al. | 2019
- 56
-
The effect of intakes of fish and Camelina sativa oil on atherogenic and anti-atherogenic functions of LDL and HDL particles: A randomized controlled trialManninen, Suvi / Lankinen, Maria / Erkkilä, Arja / Nguyen, Su Duy / Ruuth, Maija / de Mello, Vanessa / Öörni, Katariina / Schwab, Ursula et al. | 2019
- 62
-
GPVI surface expression and signalling pathway activation are increased in platelets from obese patients: Elucidating potential anti-atherothrombotic targets in obesityBarrachina, María N. / Sueiro, Aurelio M. / Izquierdo, Irene / Hermida-Nogueira, Lidia / Guitián, Esteban / Casanueva, Felipe F. / Farndale, Richard W. / Moroi, Masaaki / Jung, Stephanie M. / Pardo, María et al. | 2019
- 71
-
Risk factors for intracranial atherosclerosis: A systematic review and meta-analysisMa, Ya-Hui / Leng, Xin-Yi / Dong, Yi / Xu, Wei / Cao, Xi-Peng / Ji, Xi / Wang, Hui-Fu / Tan, Lan / Yu, Jin-Tai et al. | 2019
- 78
-
Decreased circulating catestatin levels are associated with coronary artery disease: The emerging anti-inflammatory roleChen, Yanjia / Wang, Xiaoqun / Yang, Chendie / Su, Xiuxiu / Yang, Wenbo / Dai, Yang / Han, Hui / Jiang, Jie / Lu, Lin / Wang, Haibo et al. | 2019
- 89
-
Changes in IGFBP-2 levels following a one-year lifestyle modification program are independently related to improvements in plasma apo B and LDL apo B levelsCarter, Sophie / Lemieux, Isabelle / Li, Zhuo / Alméras, Natalie / Tremblay, Angelo / Bergeron, Jean / Poirier, Paul / Després, Jean-Pierre / Picard, Frédéric et al. | 2019
- 98
-
Secondary prevention of acute coronary events with antiplatelet agents (SPACE-AA): One-year real-world effectiveness and safety cohort study in the French nationwide claims databaseBlin, Patrick / Dureau-Pournin, Caroline / Benichou, Jacques / Bonello, Laurent / Dallongeville, Jean / Danchin, Nicolas / Falissard, Bruno / Thomas-Delecourt, Florence / Jové, Jérémy / Lassalle, Regis et al. | 2019
- 107
-
Impact of multi-vessel vasospastic angina on cardiovascular outcomeHan, Seung Hwan / Lee, Kwan Yong / Her, Sung Ho / Ahn, Youngkeun / Park, Keun-Ho / Kim, Dong-Soo / Yang, Tae-Hyun / Choi, Dong-Ju / Suh, Jung-Won / Kwon, Hyuck Moon et al. | 2019
- 114
-
Constipation and risk of death and cardiovascular eventsSumida, Keiichi / Molnar, Miklos Z. / Potukuchi, Praveen K. / Thomas, Fridtjof / Lu, Jun Ling / Yamagata, Kunihiro / Kalantar-Zadeh, Kamyar / Kovesdy, Csaba P. et al. | 2019
- 121
-
The Christmas holidays are immediately followed by a period of hypercholesterolemiaVedel-Krogh, Signe / Kobylecki, Camilla J. / Nordestgaard, Børge G. / Langsted, Anne et al. | 2019
- 128
-
Growth differentiation factor-15 regulates oxLDL-induced lipid homeostasis and autophagy in human macrophagesAckermann, Kathrin / Bonaterra, Gabriel A. / Kinscherf, Ralf / Schwarz, Anja et al. | 2019
- 137
-
Differential use of E2 ubiquitin conjugating enzymes for regulated degradation of the rate-limiting enzymes HMGCR and SQLE in cholesterol biosynthesisTan, Josephine M.E. / Cook, Emma C.L. / van den Berg, Marlene / Scheij, Saskia / Zelcer, Noam / Loregger, Anke et al. | 2019
- 143
-
Fibroblast growth factor-21 levels in metabolic syndrome: Another instrument in a widening tool belt?Ajala, Oluremi / Mora, Samia et al. | 2019
- 145
-
Simon Broome confirms that the IAS definition of severe familial hypercholesterolemia predicts coronary mortality in patients with FHSantos, Raul D. / Watts, Gerald F. et al. | 2019
- 148
-
Introduction to the thematic review series on different levels of genetic regulation of cardiovascular diseasede Winther, Menno P.J. / Dallinga-Thie, Geesje M. et al. | 2019
- 150
-
Epigenetic processing in cardiometabolic diseaseCostantino, Sarah / Mohammed, Shafeeq A. / Ambrosini, Samuele / Paneni, Francesco et al. | 2019
- 159
-
Nature and nurture of tissue-specific macrophage phenotypesHoeksema, Marten A. / Glass, Christopher K. et al. | 2019
- 168
-
DNA methylation processes in atheosclerotic plaqueAavik, Einari / Babu, Mohan / Ylä-Herttuala, Seppo et al. | 2019
- 180
-
Long intergenic noncoding RNAs in cardiovascular diseases: Challenges and strategies for physiological studies and translationZhang, Xuan / Li, Daniel Y. / Reilly, Muredach P. et al. | 2019
- 189
-
Potential epigenetic therapeutics for atherosclerosis treatmentNicorescu, Ioana / Dallinga, Geesje M. / de Winther, Menno P.J. / Stroes, Erik S.G. / Bahjat, Mahnoush et al. | 2019
- 198
-
A familial hypercholesterolemia week in Kyrgyzstan: The joint scientific and practical symposium with the European Atherosclerosis Society (EAS), the International Atherosclerosis Society (IAS) and the Kyrgyz Society of Cardiology (KSC)Lunegova, Olga S. / Mirrakhimov, Erkin M. et al. | 2019
- 200
-
Association of elevated circulating fibroblast growth factor 21 levels with prevalent and incident metabolic syndrome: The Multi-Ethnic Study of AtherosclerosisOng, Kwok-Leung / McClelland, Robyn L. / Allison, Matthew A. / Kokkinos, John / Wu, Ben J. / Barter, Philip J. / Rye, Kerry-Anne et al. | 2019
- 207
-
Coronary heart disease mortality in severe vs. non-severe familial hypercholesterolaemia in the Simon Broome RegisterHumphries, Steve E. / Cooper, Jackie A. / Capps, Nigel / Durrington, Paul N. / Jones, Ben / McDowell, Ian F.W. / Soran, Handrean / Neil, Andrew H.W. et al. | 2019
- 213
-
Comments on "Optimising treatment of hyperlipidaemia: Quantitative evaluation of UK, USA and European guidelines taking account of both LDL cholesterol levels and cardiovascular disease risk"Shah, Syed Raza et al. | 2019
- 214
-
Reply to: "Comments on 'Optimising treatment of hyperlipidaemia: Quantitative evaluation of UK, USA and European guidelines taking account of both LDL cholesterol levels and cardiovascular disease risk' "Soran, Handrean / Adam, Safwaan / Durrington, Paul N. et al. | 2019
- 216
-
Bridging the treatment gap in patients at 'extreme' cardiovascular risk: Evidence from a lipid clinicBarkas, Fotios / Elisaf, Moses / Rizos, Evangelos C. / Liberopoulos, Evangelos et al. | 2019
- 219
-
Reply to: "Bridging the treatment gap in patients at 'extreme' cardiovascular risk: Evidence from a lipid clinic"Rallidis, Loukianos S. / Kiouri, Estela / Rallidi, Maria / Kosmas, Nikolaos et al. | 2019
- iii
-
Editorial board| 2019